Dr. Laura Anne Greyling, MD

Dr. Greyling practices at Gardens Plastic Surgery in Cape Coral, Florida.

Dr. Greyling's NPI, 1255620233, was assigned on March 30, 2011. Dr. Greyling graduated from USF Health Morsani College of Medicine in 2011. Dr. Greyling holds Florida license ME128226.

Dr. Greyling's primary practice is Gardens Plastic Surgery, at 413 Del Prado S Blvd, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 313-2515.

Dr. Greyling's primary practice is Gardens Plastic Surgery in Cape Coral, Florida. Dr. Greyling is also affiliated with Jupiter Medical Center. The medical group on file is AQUA Dermatology. Dmand AI also links Dr. Greyling to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greyling practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Greyling's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Greyling is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Greyling's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Greyling treats.

CMS data shows 6,244 Medicare services from Dr. Greyling across 26 procedure codes in 2024, for 1,232 Medicare patients. Medicare paid $313,959 for them. Every service was in an office.

CMS counts 1,232 Medicare patients who saw Dr. Greyling in 2024. The largest group is 65 to 74, with 706 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 1% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Greyling's median patient age at 67, with 61% women.

In 2024, Dr. Greyling wrote 1,771 Medicare Part D claims for 712 patients. 93% of them were for generic drugs. CMS names the drug for 1,592 of them, across 32 drugs with 11 or more claims each, at $310,628 in total drug cost. In 2023, CMS named 1,461 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Greyling for performance year 2024, reported as part of a group. Dr. Greyling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,001 procedures of removal of skin lesions by Dr. Greyling, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Greyling, published from 2015 to 2016. The most frequent topics are Diagnosis, Differential. Dr. Greyling has published most often in Cutis. Dr. Greyling's most frequent co-authors are Loretta S. Davis, MD, John Henry Anderson, MD and Camila Antia, MD.

CMS Open Payments shows 571 general payments to Dr. Greyling from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $2,532.

Dr. Greyling graduated from USF Health Morsani College of Medicine in 2011.

Dr. Greyling is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.